MABPRO, a.s.
🇸🇰Slovakia
- Country
- 🇸🇰Slovakia
- Ownership
- Private
- Established
- 2016-03-05
- Employees
- 11
- Market Cap
- -
- Website
- https://www.mabprotx.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours
Phase 1
Not yet recruiting
- Conditions
- TNBC - Triple-Negative Breast CancerNon-small-cell Lung CarcinomaClear Cell Renal Cell Carcinoma MetastaticHead and Neck CancerMesothelioma, Malignant
- Interventions
- First Posted Date
- 2023-01-26
- Last Posted Date
- 2023-03-15
- Lead Sponsor
- Mabpro, a.s.
- Target Recruit Count
- 50
- Registration Number
- NCT05698238
News
No news found